T1	Participants 337 364	heart failure (HF) patients
T2	Participants 509 540	HF patients with coexisting OSA
T3	Participants 798 888	medically treated HF patients (EF <45%) and OSA (apnea-hypopnea index > or =20/h of sleep)
T4	Participants 1068 1089	nine control patients
T5	Participants 1195 1219	8 CPAP-treated patients,
